These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 19467983

  • 1. [Breast cancer chemoprevention. Rational, trials results and future].
    Cutuli B, Lesur A, Namer M, Kerbrat P.
    Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983
    [Abstract] [Full Text] [Related]

  • 2. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ, Craig Jordan V.
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [Abstract] [Full Text] [Related]

  • 3. Prevention of hormone-related cancers: breast cancer.
    Dunn BK, Wickerham DL, Ford LG.
    J Clin Oncol; 2005 Jan 10; 23(2):357-67. PubMed ID: 15637398
    [Abstract] [Full Text] [Related]

  • 4. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M, Kodama T.
    In Vivo; 2001 Jan 10; 15(4):319-25. PubMed ID: 11695224
    [Abstract] [Full Text] [Related]

  • 5. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG, Costantino JP, Wickerham DL, Cronin WM.
    Clin Cancer Res; 2003 Jan 10; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [Abstract] [Full Text] [Related]

  • 6. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct 10; 10(2):1-2. PubMed ID: 12393316
    [No Abstract] [Full Text] [Related]

  • 7. Chemoprevention of breast cancer: recommendations and rationale.
    Berg AO, U.S. Preventive Services Task Force.
    Am J Nurs; 2003 May 10; 103(5):107, 109, 111, 113. PubMed ID: 12759615
    [No Abstract] [Full Text] [Related]

  • 8. Risk-reducing strategies for breast cancer--a review of recent literature.
    Mokbel K.
    Int J Fertil Womens Med; 2003 May 10; 48(6):274-7. PubMed ID: 15646397
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Breast Cancer Continuum: insights from the tamoxifen trials impact future drug development strategies.
    Lewis JP.
    Ann N Y Acad Sci; 2001 Dec 10; 949():327-32. PubMed ID: 11795371
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen for breast cancer prevention.
    Breckwoldt M, Karck U.
    Exp Clin Endocrinol Diabetes; 2000 Dec 10; 108(4):243-6. PubMed ID: 10961352
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tamoxifen in ductal carcinoma in situ.
    Daly MB.
    Semin Oncol; 2006 Dec 10; 33(6):647-9. PubMed ID: 17145343
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
    Vogel VG.
    Ann N Y Acad Sci; 2006 Nov 10; 1089():127-42. PubMed ID: 17261762
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chemoprevention of breast cancer.
    O'Regan RM.
    Cancer Treat Res; 2000 Nov 10; 103():183-207. PubMed ID: 10948447
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.